RaySearch Laboratories AB (STO:RAY.B), a provider of software for radiation therapy, announced on Friday that it has secured an order worth DKK10.5m (approximately SEK15.4m) from Odense University Hospital, part of the South Denmark Region, for its RayStation treatment planning system.
Odense University Hospital's radiotherapy centre, a leader in automated treatment planning, aims to further expand automation across the entire planning process, from initial assessments to finalised treatment plans. RayStation was selected following an extensive market evaluation focused on supporting continued innovation in automation.
RayStation integrates both machine learning and traditional planning algorithms. Its upcoming version will feature a new auto-optimisation algorithm, currently under development in collaboration with Memorial Sloan Kettering Cancer Center.
Most of the revenue from the order is expected to be recognized in the first quarter of 2025. The agreement excludes a service contract and remains subject to regulatory clearance in certain markets.
(USD1.00 = DKK6.57)
Genprex signs new research agreement with University of Pittsburgh to advance diabetes gene therapy
AstraZeneca and Daiichi Sankyo's Enhertu shows strong results in early-stage breast cancer trial
Adcentrx's ADRX-0706 granted US FDA Fast Track designation to treat advanced cervical cancer
AstraZeneca secures EU approval for Calquence combo as first-line treatment in mantle cell lymphoma
Phanes Therapeutics doses first patient in peluntamig-atezolizumab combination clinical study
Otsuka's leukaemia drug ponatinib launched on Fangzhou platform
TransCode Therapeutics announces reverse stock split
Seegene presrnts CURECA conceptual video at ESCMID Global 2025
FDA accepts Novo Nordisk's filing application for oral semaglutide 25 mg
Nutshell Therapeutics' NTS071 p53 allosteric reactivator cleared for US clinical trial